Drawing from all-cause mortality data across 17 countries, the study found a significant increase in deaths—particularly among the elderly—following the introduction of third and fourth booster doses.
A panel from the Food and Drug Administration (FDA) unanimously decided that the ingredient phenylephrine is not effective in relieving cold and flu symptoms.
